Look at mergers and acquisitions ｜ TPTX: Husbands and wives are together, their profits are broken

Recent

TPTX was co -founded by Dr. Cui Jingrong, a Chinese scientist and Dr. Li Yishan in 2013. This is the same as the entrepreneurial teacher. In 9 years, it has developed a series of clinical tumor drugs in TPTX. Breakthrough treatment is qualified, and clinical pipelines that also have multiple popular targets such as MET/RET/ALK inhibitors and Claudin18.2, which can be described as "star players" and "substitute bench thickness". Before the transaction, as the exclusive authorized party of the Greater China of RepotRctinib, Ding Ding Pharmaceutical disclosed the main data of Chinese patients in the phase I/II Trident-1 test, and 11%of Chinese patients were 91%. God's help appeared, and BMS decisively gave 122%of the offer to acquire offers.

"Zhouyi · Department of Temple" has a saying that the two of them are together and their profits are broken. The alumni of the Chinese University of Science and Technology entrepreneurship, the acquisition of BMS is a certificate of disconnection. In March 2021, the two "made a baby" again (setting Blossomhill therapeutics), which can be described as peaches and Li.

Oriental Gaosheng M & A Xueyuan Products

- END -